ProfileGDS4718 / 218044_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 62% 60% 65% 58% 54% 55% 72% 63% 65% 61% 55% 58% 52% 56% 64% 59% 57% 55% 59% 68% 60% 62% 64% 60% 59% 58% 55% 63% 56% 57% 55% 64% 63% 56% 55% 62% 65% 62% 59% 63% 58% 50% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1234360
GSM549102patient 115, normal, homogenized [OPG study]6.2720462
GSM549104patient 119, normal, homogenized [OPG study]6.1297660
GSM549108patient 138, normal, homogenized [OPG study]6.4728965
GSM549119patient 077, normal, homogenized [OPG study]6.0181158
GSM549133patient 032, cancer, homogenized [OPG study]5.7300454
GSM549139patient 042, cancer, homogenized [OPG study]5.7840755
GSM549099patient 107, normal, homogenized [OPG study]6.9978872
GSM549109patient 139, normal, homogenized [OPG study]6.3434663
GSM549110patient 046, normal, homogenized [OPG study]6.452265
GSM549114patient 063, normal, homogenized [OPG study]6.1240461
GSM549122patient 082, normal, homogenized [OPG study]5.8336955
GSM549134patient 033, cancer, homogenized [OPG study]5.9411858
GSM549136patient 036, cancer, homogenized [OPG study]5.5517252
GSM549140patient 044, cancer, homogenized [OPG study]5.8191956
GSM549111patient 047, normal, homogenized [OPG study]6.4460364
GSM549113patient 057, normal, homogenized [OPG study]6.0565459
GSM549132patient 031, cancer, homogenized [OPG study]5.9038957
GSM549137patient 038, cancer, homogenized [OPG study]5.8273155
GSM549142patient 047, cancer, homogenized [OPG study]6.1537759
GSM549100patient 110, normal, homogenized [OPG study]6.6554268
GSM549107patient 135, normal, homogenized [OPG study]6.0863360
GSM549115patient 068, normal, homogenized [OPG study]6.2593862
GSM549116patient 072, normal, homogenized [OPG study]6.4438264
GSM549120patient 078, normal, homogenized [OPG study]6.1011360
GSM549131patient 030, cancer, homogenized [OPG study]6.0266959
GSM549118patient 074, normal, homogenized [OPG study]6.0025258
GSM549129patient 027, cancer, homogenized [OPG study]5.8247455
GSM549123patient 088, normal, homogenized [OPG study]6.319563
GSM549124patient 006, cancer, homogenized [OPG study]5.9197156
GSM549126patient 015, cancer, homogenized [OPG study]5.8960157
GSM549128patient 025, cancer, homogenized [OPG study]5.855
GSM549103patient 117, normal, homogenized [OPG study]6.384564
GSM549117patient 073, normal, homogenized [OPG study]6.2617963
GSM549138patient 041, cancer, homogenized [OPG study]5.8915356
GSM549141patient 045, cancer, homogenized [OPG study]5.7885355
GSM549130patient 028, cancer, homogenized [OPG study]6.2218562
GSM549101patient 111, normal, homogenized [OPG study]6.4673965
GSM549105patient 128, normal, homogenized [OPG study]6.2694462
GSM549106patient 134, normal, homogenized [OPG study]6.0502359
GSM549112patient 048, normal, homogenized [OPG study]6.3594663
GSM549125patient 011, cancer, homogenized [OPG study]5.9989158
GSM549127patient 024, cancer, homogenized [OPG study]5.5389450
GSM549135patient 035, cancer, homogenized [OPG study]5.6513453